Formats
  1. Journal Article (66963)
  2. Meeting Abstract (33963)
  3. Book Section (5116)
  4. Review (3804)
  5. Editorial (2206)
  6. Conference Paper (1527)
  7. Correspondence (670)
  8. Guidelines (668)
  9. Research Letter (555)
  10. Book Whole (345)
  11. Miscellaneous (341)
Groups
  1. Department of Medicine (39305)
  2. GSK Faculty (22555)
  3. Solid Tumor Oncology Division (22161)
  4. Surgery (21345)
  5. Survivorship Research (15844)
  6. Sloan Kettering Institute Faculty (15680)

More Groups

People
  1. Marc Ladanyi (1330)
  2. Robert Motzer (1246)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Sergio Giralt (1062)
  6. Murray Brennan (1059)

More People

Years
  1. 2026 (1)
  2. 2025 (2479)
  3. 2024 (5593)
  4. 2023 (5808)
  5. 2022 (6169)
  6. 2021 (5720)

More Years

Publications
  1. Journal of Clinical Oncology (8678)
  2. Blood (5165)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2614)
  5. Laboratory Investigation (1890)
  6. Modern Pathology (1814)

More Publications

Publishers
  1. Elsevier Inc. (13895)
  2. American Society of Clinical Oncology (9263)
  3. Springer (7206)
  4. Nature Publishing Group (6403)
  5. American Association for Cancer Research (6015)
  6. American Society of Hematology (5537)

More Publishers

Results (116158)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Multiple myeloma and comorbidity: A population-based study
    Meeting Abstract

    Sverrisdottir, I.; Rognvaldsson, S.; Turesson, I.; Hultcrantz, M.; Bjorkholm, M.; Landgren, C. O.; Kristinsson, S.
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Interleukin-6 (IL-6) blockade with siltuximab peri-autologous hematopoietic stem cell transplantation (AHCT) may reduce symptom burden by altering the cytokine milieu in older patients with multiple myeloma (MM)
    Meeting Abstract

    Shah, G.; Holder, J.; Cho, S.; Murata, K.; Devlin, S.; Hoover, E.; Chung, D.; Dahi, P.; Lahoud, O.; Scordo, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Successful pharmacokinetic (PK)-directed dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for Multiple Myeloma (MM) and AL Amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT)
    Meeting Abstract

    Shah, G.; Lin, A.; Grumley, A.; Kamrowski, A.; Schofield, R.; Devlin, S.; Bhatt, V.; Proli, A.; Chung, D.; Dahi, P.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Depth of response and outcomes by initial therapy prior to autologous hematopoietic stem cell transplantation for multiple myeloma
    Meeting Abstract

    Shah, G.; Chung, D.; Scordo, M.; Seier, K.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Lesokhin, A.; Mailankody, S.; Shah, U.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • A phase 1b study of once-weekly carfilzomib combined with lenalido-mide and dexamethasone (wKRd) in patients (pts) with newly diagnosed multiple myeloma (NDMM)
    Meeting Abstract

    Alsina, M.; Landgren, C. O.; Raje, N.; Niesvizky, R.; Bensinger, W. I.; Berdeja, J.; Kovacsovics, T.; Vesole, D.; Fang, B.; Kimball, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Analysis of the genomic and transcriptomic landscape of chemoresistant multiple myeloma
    Meeting Abstract

    Ziccheddu, B.; Biancon, G.; Dugo, M.; Devecchi, A.; De Philippis, C.; Bagnoli, F.; Maura, F.; De Cecco, L.; Gimondi, S.; Vendramin, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • A prospective study of circulating chemokines and angiogenesis markers and risk of multiple myeloma and its precursor
    Meeting Abstract

    Hofmann, J.; Landgren, C. O.; Landy, R.; Kemp, T.; Santo, L.; McShane, C.; Shearer, J.; Lan, Q.; Rothman, N.; Pinto, L.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Biomarker based targeting of the epichaperome as a novel therapeutic approach for multiple myeloma (MM)
    Meeting Abstract

    Lopes, E. C.; Wang, T.; Jayabalan, D.; Monge, J.; Taldone, T.; Contreras, J.; Yip, W.; Panchal, P.; Sharma, S.; Digwal, C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Practice patterns with focal progression on daratumumab therapy
    Meeting Abstract

    Bal, S.; Peterson, T.; Landau, H.; Chung, D.; Giralt, S.; Korde, N.; Mailankody, S.; Smith, E.; Shah, U.; Hultcrantz, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Clinical and biological early relapse predictors in multiple myeloma: An analysis from the MMRF CoMMpass study
    Meeting Abstract

    D'Agostino, M.; Zaccaria, G. M.; Ziccheddu, B.; Genuardi, E.; Maura, F.; Oliva, S.; Auclair, D.; Yesil, J.; Capra, A.; Colucci, P.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save